Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Robert J Henning"'
Autor:
Robert J Henning
Publikováno v:
Future cardiology. 18(7)
Handheld 2D ultrasound devices (HUDs) have become available as an adjunct to physical examinations, visualizing the heart and lungs in real time and facilitating prompt patient diagnosis and treatment of cardiopulmonar.y disorders. These devices prov
Autor:
Robert J, Henning
Publikováno v:
Am J Cardiovasc Dis
Tricuspid regurgitation (TR) is present in 1.6 million individuals in the United States and 3.0 million people in Europe. Functional TR, the most common form of TR, is caused by cardiomyopathies, LV valve disease, or pulmonary disease. The five-year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4793f7976b39f503cc50772d3fb86cdd
https://europepmc.org/articles/PMC8918740/
https://europepmc.org/articles/PMC8918740/
Autor:
Robert J Henning
Publikováno v:
Future Cardiology. 16:317-342
Approximately 50 million adults worldwide have known congenital heart disease (CHD). Among the most common types of CHD defects in adults are atrial septal defects and ventricular septal defects followed by complex congenital heart lesions such as te
Autor:
Robert J Henning
Publikováno v:
Journal of Cardiovascular Translational Research. 14:195-212
Cardiac exosomes mediate cell-to-cell communication, stimulate or inhibit the activities of target cells, and affect myocardial hypertrophy, injury and infarction, ventricular remodeling, angiogenesis, and atherosclerosis. The exosomes that are relea
Autor:
Robert J, Henning
Publikováno v:
Am J Cardiovasc Dis
Two billion people worldwide older than 18 years of age, or approximately 30% of the world population, are overweight or obese. In addition, more than 43 million children under the age of 5 are overweight or obese. Among the population in the United
Autor:
Robert J Henning
Publikováno v:
Future Cardiology. 15:197-225
Heart disease is the leading cause of death among women in the industrialized world. However, women after myocardial infarctions (MIs) are less likely to receive preventive medications or revascularization and as many as 47% experience heart failure,
Autor:
Robert J Henning
Publikováno v:
Future cardiology. 18(1)
Mitral valve regurgitation (MR) is due primarily to either primary degeneration of the mitral valve with Barlow's or fibroelastic disease or is secondary to ischemic or nonischemic cardiomyopathies. Echocardiography is essential to assess MR etiology
Autor:
Robert J Henning
Publikováno v:
Future cardiology. 17(6)
Aortic valve stenosis (AS) is the third most frequent cardiovascular abnormality after coronary artery disease and hypertension. A bicuspid aortic valve is the most common cause for AS until seventh decade and calcific valve degeneration is responsib
Publikováno v:
Cell Transplantation, Vol 22 (2013)
We have previously demonstrated in acute myocardial infarctions that human umbilical cord blood mononuclear cells (HUCBCs), which contain hematopoietic, endothelial, and mesenchymal stem cells, reduce acute myocardial infarction size by ≥50% and pr
Externí odkaz:
https://doaj.org/article/000ebc16af104921bca7a28f553d86b7
Publikováno v:
AIMS Cell and Tissue Engineering, Vol 2, Iss 4, Pp 220-237 (2018)
Stem cell paracrine factors are beneficial in myocardial infarction (MI) treatment. However, specific stem cell factor effects on myocardial cytokines and their molecular pathways have not been precisely identified. We treated 44 rats with MIs with i